Print

HVTN 205

Phase IIa trial testing the safety and immunogenicity of GeoVax's HIV-1 DNA prime followed by GeoVax?s HIV-1 MVA (Modified Vaccinia Virus) boost.

Trial Details:

IIa Completed
GeoVax, HIV Vaccine Trials Network (HVTN) January 12, 2009
pGA2/JS7 DNA,MVA/HIV62
pGA2/JS7 DNA DNA
MVA/HIV62 Viral Vector - Pox
Peru, USA 299
http://clinicaltrials.gov/ct2/show/NCT00820846?term=HVTN+205&rank=2